We are writing to invite your institution to participate in a multicenter retrospective cohort study titled:
"PAUSE CAT" [Perioperative Anticoagulation Use and Suspension Evaluation in Cancer-Associated Thrombosis]
This collaborative project aims to better understand thrombotic and bleeding outcomes in patients with newly diagnosed cancer-associated thrombosis undergoing procedures requiring temporary anticoagulation interruption.
Study Highlights:
Design: Retrospective chart review via EMR
Inclusion: Adults with active malignancy and new VTE undergoing a procedure within 30 days of VTE diagnosis
Outcomes: Recurrent VTE, embolic events, bleeding complications, and mortality within 6 months
Data Collection: Standardized REDCap form
Site Requirements: Local IRB approval and data use agreement
This study represents a valuable opportunity to advance our understanding of real-world anticoagulation complications in high-risk oncology populations, and we hope to include a diverse cohort of institutions.
If your team is interested in participating or would like more information, please don’t hesitate to reach out. We would be happy to set up a meeting to discuss logistics and next steps.
Avi Leader
Memorial Sloan Kettering Cancer Center
leadera@mskcc.org
Rushad Patell
Beth Israel Deaconess Medical
Centerrpatell@bidmc.harvard.edu